Report on Pediatric Brain Tumor Consortium (PBTC)-029b, a prospective phase 2 clinical trial of selumetinib in treating young patients with recurrent/progressive low-grade glioma: New results on strata 2, 5, and 6 with updated long-term survival outcomes on strata 1, 3, and 4 Meeting Abstract
| Authors: | Fangusaro, J.; Onar-Thomas, A.; Poussaint, T. Y.; Lensing, S.; Ligon, A. H.; Lindeman, N.; Banerjee, A.; Kilburn, L.; Lenzen, A.; Pillay-Smiley, N.; Pollack, I. F.; Robison, N.; Partap, S.; Qaddoumi, I.; Landi, D.; Jones, D. T. W.; Stewart, C. F.; Fouladi, M.; Dunkel, I. J. |
| Abstract Title: | Report on Pediatric Brain Tumor Consortium (PBTC)-029b, a prospective phase 2 clinical trial of selumetinib in treating young patients with recurrent/progressive low-grade glioma: New results on strata 2, 5, and 6 with updated long-term survival outcomes on strata 1, 3, and 4 |
| Meeting Title: | 21st International Symposium on Pediatric Neuro-Oncology (ISPNO 2024) |
| Journal Title: | Neuro-Oncology |
| Volume: | 26 |
| Issue: | Suppl. 4 |
| Meeting Dates: | 2024 Jun 28-July 2 |
| Meeting Location: | Philadelphia, PA |
| ISSN: | 1522-8517 |
| Publisher: | Oxford University Press |
| Date Published: | 2024-06-01 |
| Language: | English |
| ACCESSION: | WOS:001252720000515 |
| DOI: | 10.1093/neuonc/noae064.398 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: LGG-05 -- Source: Wos |
